A pilot study of heat immunotherapy using cationic magnetoliposome for advanced melanoma patients - combined therapy with topical imiquimod immunotherapy
- Conditions
- melanoma
- Registration Number
- JPRN-UMIN000006414
- Lead Sponsor
- Department of Dermatology, Shinshu University School of Medicine
- Brief Summary
The trial was terminated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Not provided
1. An anti-ancer therapy has been recieved within previoous 4 weeks 2. Patients who have brain matastases 3. Patients who have a life expectancy of less than 6 months 4. Patients who are pregnant or nursing 5. Patients who have severe pleural or pericardial effusion or ascites 6. Patients who have active infection 7. Patients who have other malignancies 8. Patients who are unable to keep protocol due to psychiatric, familial, social or traffic disadvantage 9. Patients who have metals inside the body near (within 10 cm) the lesion where alternative magnetic field is put 10. Patients who have active asthma, or have had severe anaphilaxis before 11. Patients who are judged inappropriate to be enrolled in this study by clinical investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DLT AE Local antitumor effect
- Secondary Outcome Measures
Name Time Method